|
Wednesday, 09 January 2019 20:06 |
|
Following successful beta program, the Simoa SP-X next generation benchtop and CorPlex are launching ahead of schedule to further revolutionize cancer research, immunotherapy monitoring, and drug development |
|
Read more...
|
|
Wednesday, 09 January 2019 20:06 |
|
Following successful beta program, the Simoa SP-X next generation benchtop and CorPlex are launching ahead of schedule to further revolutionize cancer research, immunotherapy monitoring, and drug development |
|
Read more...
|
|
Wednesday, 09 January 2019 20:06 |
|
Skincare and Beauty Industry Veteran to Lead Topix into the Future |
|
Read more...
|
|
Wednesday, 09 January 2019 20:06 |
|
Skincare and Beauty Industry Veteran to Lead Topix into the Future |
|
Read more...
|
|
Wednesday, 09 January 2019 05:06 |
|
Bioasis Technologies, Inc.Catherine London+1-917-763-2709
This e-mail address is being protected from spambots. You need JavaScript enabled to view it
|
|
Read more...
|
|
Wednesday, 09 January 2019 05:06 |
|
ResearchAndMarkets.comLaura Wood, Senior Press Manager
This e-mail address is being protected from spambots. You need JavaScript enabled to view it
For E.S.T Office Hours Call 1-917-300-0470For U.S./CAN Toll Free Call 1-800-526-8630For GMT Office Hours Call +353-1-416-8900Related Topics: Liver and Kidney Disorders Drugs |
|
Read more...
|
|
Wednesday, 09 January 2019 05:06 |
|
Study Tests Elimination Of Chemotherapy And Expands Upon Previous Combination Study Of NK Cell Therapy With N-803 Showing Promising Clinically Meaningful Responses In Merkel Cell Carcinoma Patients |
|
Read more...
|
|
Wednesday, 09 January 2019 05:06 |
|
Jane ByramSCORR Marketing512.626.2758
This e-mail address is being protected from spambots. You need JavaScript enabled to view it
|
|
Read more...
|
|
Wednesday, 09 January 2019 05:06 |
|
-Data Consistent with ECHELON-1 Trial Outcome Showing Superior Clinical Activity of ADCETRIS in Combination with AVD when Compared to ABVD in Frontline Advanced Hodgkin Lymphoma- |
|
Read more...
|
|
Wednesday, 09 January 2019 05:06 |
|
ResearchAndMarkets.comLaura Wood, Senior Press Manager
This e-mail address is being protected from spambots. You need JavaScript enabled to view it
For E.S.T Office Hours Call 1-917-300-0470For U.S./CAN Toll Free Call 1-800-526-8630For GMT Office Hours Call +353-1-416-8900Related Topics: Biomaterials |
|
Read more...
|
